BRPI0505478ABRPI0505478ABRPI0505478ABR PI0505478 ABRPI0505478 ABR PI0505478ABR PI0505478 ABRPI0505478 ABR PI0505478ABR PI0505478 ABRPI0505478 ABR PI0505478A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metrisa Metalurgica TriangulofiledCriticalMetrisa Metalurgica Triangulo
Priority to BRPI0505478priorityCriticalpatent/BRPI0505478A/en
Publication of BRPI0505478ApublicationCriticalpatent/BRPI0505478A/en
INJETOR DE COLA A presente invenção refere-se a um injetor de cola para ser usado em máquina de aplicar cola em madeira, dotado de um cilindro penumático (2) responsável por impulsionar a cola ao pente (4) de aplicação de cola; um conjunto de regulagem (7) de distância do conjunto à madeira; um conjunto de regulagem da altura do conjunto (6); dito cilindro (2) compreende uma haste (15) dotada de uma ponteira (11) cilíndrica que se desloca impelindo a cola para o pente (4) através de seu canal de entrada (41), e que na sua interrupção da injetora retorna a sua posição inicial sem deixar resíduos de cola no canal de entrada do pente (4), o que permite uma dosagem precisa de cola sobre as peças a serem coladas, evitando desperdícios.Glue Injector The present invention relates to a glue injector for use in a wood gluing machine, provided with a feather cylinder (2) responsible for propelling the glue to the glue comb (4); a set of adjustment (7) away from the set to the wood; a set height adjustment assembly (6); said cylinder (2) comprises a rod (15) provided with a cylindrical nozzle (11) which moves the glue to the comb (4) through its inlet channel (41), and upon its interruption of the injector returns to its initial position without leaving glue residues in the comb inlet channel (4), which allows precise dosing of glue on the pieces to be glued, avoiding waste.
COMPOUNDS DERIVED FROM PYRIDOPIRIMIDINONES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIRATORY DISEASES AND PSYCHIATRIC DISEASES.
COMPOUNDS DERIVED FROM SULFONIL-FENIL-2H- [1,2,4] OXADIAZOL-5-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; PREPARATION PROCEDURE; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLISM DISORDERS, AS DIABETES MELLITUS, DIS
COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
Compound 4- [5 (2-amino-ethanesulfonyl) -isoquinolin-7-yl] -phenolo a pharmaceutically acceptable salt or a hydrate or salt thereof; pharmaceutical composition comprising said compound, lyophilized pharmaceutical composition; and use of the compound as antineiplasic and / or antiviral.
COMPOUNDS DERIVED FROM PIRAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.
COMPOUNDS DERIVED FROM PYRIMIDINS 2,4,5 TRI-SUBSTITUTES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF CANCER.
Imidazolin-2,4 methyl phenoxy substituted diones, pharmaceutical composition containing these compounds and their use in metabolic syndrome, obesity, diabetes, CNS disorders, schizophrenia, Alzheimer's, alcohol and nicotine dependence.
COMPOUNDS DERIVED FROM 2,3-BENZODIAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PSYCHOTIC DISORDERS.
COMPOUNDS DERIVED FROM MACROLIDOS; PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN INFECTIONS.
Process for the preparation of a 1,3-oxathiolane, for the preparation of lamivudine and for the isolation of lamivudine, lamivudine and pharmaceutical composition
PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INCLUSION COMPLEX FORMED BY DISULFIRAM AND A CYCLODEXTRINE; AND ITS USE FOR THE TREATMENT OF THE ALCOHOL AND COCAINE DEPENDENCE.
Legal Events
Date
Code
Title
Description
B11A
Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y
Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired